Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | RORC | P51449 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 4/20 | 0.37 |
| ▸ | LARS1 | Q9P2J5 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | ERN1 | O75460 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | XBP1 | P17861 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12300309 | 0.79 | L3MBTL1 (0.42) | MAPTL3MBTL1RORCRAB9AATM | |
| SCHEMBL4881673 | 0.78 | ALDH1A1 (0.38) | MAPTL3MBTL1RAB9AHPGDALDH1A1 | |
| SCHEMBL4889741 | 0.77 | LMNA (0.36) | MAPTL3MBTL1RORCRAB9AATM | |
| SCHEMBL29954273 | 0.72 | TSHR (0.39) | L3MBTL1RORCATMTSHRHPGD | |
| SCHEMBL16668301 | 0.72 | TSHR (0.39) | L3MBTL1RORCATMTSHRHPGD | |
| SCHEMBL21192744 | 0.71 | ERN1 (0.43) | MAPTL3MBTL1RORCRAB9AATM | |
| SCHEMBL3785688 | 0.70 | ALDH1A1 (0.52) | MAPTL3MBTL1RAB9AATMALDH1A1 | |
| SCHEMBL1547751 | 0.69 | L3MBTL1 (0.54) | MAPTL3MBTL1RAB9AATMTSHR | |
| SCHEMBL19155762 | 0.69 | MAPT (0.41) | MAPTL3MBTL1RORCRAB9AATM | |
| SCHEMBL18052935 | 0.69 | MAPT (0.41) | MAPTL3MBTL1RORCRAB9AATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1817318-B1 | STABILIZING METHOD AND STABILIZED COMPOSITION FOR ARYL BORON COMPOUNDS | NIPPON CATALYTIC CHEM IND (JP) | 2013-08-28 | — | — | EP | disclosed |
| US-20080154065-A1 | Stabilizing Method and Stabilized Composition for Aryl Boron Compounds | NIPPON SHOKUBAI CO., LTD. (JP) | 2008-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080154065-A1 | Stabilizing Method and Stabilized Composition for Aryl Boron Compounds | AR, AHR, BCL6 | MAPT 1790/4885L3MBTL1 2660/4885RORC 959/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.